Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Bradykinin B2 inhibitor | Is a | Enzyme inhibitor | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Bradykinin B2 inhibitor | Is a | Drug or medicament (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Bradykinin B2 inhibitor | Has disposition | Bradykinin B2 receptor antagonist (disposition) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Bradykinin B2 inhibitor | Is a | Substance categorized by disposition | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
Bradykinin B2 inhibitor | Is a | Substance with receptor antagonist mechanism of action (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Icatibant (substance) | Is a | True | Bradykinin B2 inhibitor | Inferred relationship | Existential restriction modifier (core metadata concept) | |
Product containing bradykinin B2 inhibitor (product) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | True | Bradykinin B2 inhibitor | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 |
Icatibant acetate | Is a | True | Bradykinin B2 inhibitor | Inferred relationship | Existential restriction modifier (core metadata concept) |
This concept is not in any reference sets